Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMoneysupermarket.Com Regulatory News (MONY)

Share Price Information for Moneysupermarket.Com (MONY)

Share Price is delayed by 15 minutes
Get Live Data
182.20    1.60 (0.89%)
Bid:
181.90
Ask:
182.10
Spread: 0.20 (0.11%)
Market Cap: £942.79m
MONY Live PriceLast checked at - London Stock Exchange

Intraday Moneysupermarket.Com Share Chart

Q3 Trading Statement

17 Oct 2019 07:00

RNS Number : 1428Q
Moneysupermarket.com Group PLC
17 October 2019
 

17 October 2019

Q3 2019 Update: Revenue grows 4% as energy outperforms

Moneysupermarket.com Group PLC reports trading results for the quarter ended 30 September 2019

 

 

3 months to

30 September 2019

9 months to

30 September 2019

 

£m

Growth %

£m

Growth %

Insurance

49.9

3

146.0

3

Money

20.6

(5)

67.2

1

Home services

17.7

21

51.9

40

Other revenue*

12.7

10

35.1

41

Total

100.9

4

300.2

11

*Other revenue in Q3 includes £6.6m attributable to Decision Technologies which was acquired 9 August 2018

 

§ Insurance grew in a subdued premium environment despite some volatility in our natural search rankings

 

§ Money underperformed due to the continuing challenges in product availability

 

§ Energy switching remained strong due to the great provider offers and large customer savings

 

 

Mark Lewis, CEO of Moneysupermarket Group, said:

"The group continued to grow in the quarter, with strong trading in energy showing that there are still big savings to be made by customers even though the price cap is lower. 

"Even better, our Reinvent strategy continues to do more for our customers - the new MoneySuperMarket Energy Monitor service means our customers need never overpay for energy ever again."

 

Outlook:

We expect the overall trading dynamics to continue to the end of the year and within that Money to weaken. The Board remains confident of meeting current market expectations for the full year.

 

For further information, contact:

Scilla Grimble Chief Financial Officer Scilla.Grimble@moneysupermarket.com / 0207 379 5151

Jo Britten Investor Relations Director Jo.Britten@moneysupermarket.com / 0789 646 9380

William Clutterbuck Maitland AMO wclutterbuck@maitland.co.uk / 0207 379 5151

 

Notes:

Adjusted EBITDA is operating profit adjusted for depreciation, amortisation and other non-underlying costs including strategy related costs.

Market expectations for the 12 months to 31 December 2019 (from the analyst consensus on our investor website) are in a range of £138.1m to £144.6m, with an average of £141.9m.

 

 

This statement may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward-looking statements to reflect events or developments occurring after the date such statements are published. The information in this release is based on management information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTMFBFTMBTBBRL
Date   Source Headline
5th Apr 20191:20 pmRNSHolding(s) in Company
29th Mar 20199:07 amRNSDirector/PDMR Shareholding
29th Mar 20199:00 amRNSTotal Voting Rights
5th Mar 20192:58 pmRNSHolding(s) in Company
5th Mar 20197:00 amRNSAnnual Financial Report
28th Feb 201910:00 amRNSTotal Voting Rights
25th Feb 20192:02 pmRNSDirector/PDMR Shareholding
25th Feb 20197:00 amRNSHolding(s) in Company
15th Feb 20192:16 pmRNSDirector/PDMR Shareholding
15th Feb 20192:15 pmRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSDirectorate Change
14th Feb 20197:00 amRNSFinal Results
6th Feb 20192:53 pmRNSHolding(s) in Company
31st Jan 20198:30 amRNSBlock listing Interim Review
31st Jan 20198:30 amRNSTotal Voting Rights
31st Dec 20189:00 amRNSTotal Voting Rights
30th Nov 20181:10 pmRNSTotal Voting Rights
30th Nov 20189:37 amRNSHolding(s) in Company
16th Nov 20189:11 amRNSHolding(s) in Company
11th Oct 201811:47 amRNSDirector/PDMR Shareholding
11th Oct 20187:00 amRNSTrading Statement
4th Oct 201812:59 pmRNSScilla Grimble - Appointment Date Confirmation
28th Sep 20189:00 amRNSTotal Voting Rights
19th Sep 20189:19 amRNSDirector/PDMR Shareholding
11th Sep 20189:30 amRNSDirector/PDMR Shareholding
24th Aug 20181:09 pmRNSDirector/PDMR Shareholding
10th Aug 201811:21 amRNSHolding(s) in Company
10th Aug 20187:00 amRNSCompletion of acquisition of Decision Technologies
7th Aug 20187:11 amRNSAcquisition of Decision Technologies Limited
2nd Aug 20187:00 amRNSDirectorate Change
31st Jul 20189:00 amRNSBlock listing Interim Review
19th Jul 20187:00 amRNSHalf-year Report
29th Jun 20189:00 amRNSTotal Voting Rights
13th Jun 201810:25 amRNSDirector Declaration
31st May 20189:00 amRNSTotal Voting Rights
17th May 20187:00 amRNSDirectorate Change
3rd May 20181:52 pmRNSResult of AGM
3rd May 201811:47 amRNSResult of Meeting
1st May 20188:31 amRNSDirector/PDMR Shareholding
1st May 20188:27 amRNSTotal Voting Rights
26th Apr 20182:02 pmRNSDirector/PDMR Shareholding
19th Apr 20183:32 pmRNSHolding(s) in Company
18th Apr 20187:00 amRNSTrading Statement
5th Apr 20185:37 pmRNSDirector/PDMR Shareholding
5th Apr 20185:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20187:00 amRNSDirector/PDMR Shareholding
29th Mar 20187:00 amRNSAcquisition of Decision Technologies Limited
7th Mar 20186:03 pmRNSAnnual Financial Report
1st Mar 20187:00 amRNSDirectorate Change - Appointment of Sarah Warby
28th Feb 20189:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.